RXFP1 and pulmonary fibrosis: Relaxin also displays anti-fibrotic properties in various preclinical models of hepatic, pulmonary, renal and cardiovascular fibrosis while RXFP1 knockout mice develop perivascular pulmonary fibrosis with time8.